Use access key #2 to skip to page content.
$9.87 0.42 (4.44%)
12/4/2008 12:20 PM

CryoLife, Inc. (CRY)

CAPS Rating:
****

The Company develops and commercializes biomaterials, implantable medical devices, and preserves and distributes human tissues for cardiovascular and vascular transplant applications.

Rating a stock in CAPS consists of three components:

Your call - Will this stock outperform or underperform the S&P 500? Successful picks are measured in terms of whether or not you were correct and by how many percentage points.

Your time frame - A guideline for other members to see whether your thinking is short or long-term. Time frame is also used to calculate the stock rating, but is not used in the scoring of your pick.

Your pitch - Here's your chance to offer more detailed thoughts, analysis, concerns, or the rationale behind your call. The pitch is optional and may be added later.

Each time you rate a stock, CAPS updates the community intelligence for the company, which may or may not change its CAPS rating. For more information, visit the Help tab at the top of the page.

You aren't currently rating CRY

Add Stock to Watchlist

What the Community Thinks

Total Members

158 Outperforms
10 Underperforms
 

All-Stars

32 Outperforms
4 Underperforms
 

Wall Street

3 Outperforms
0 Underperforms
 

Members bullish on CRY are also bullish on:

Members bearish on CRY are also bearish on:

Ticker Tags

It's a Verb! (42), Healthcare Equipment and Supplies (183), Georgia (18), Micro Cap (4924), Specialized Health Services (6)
Suggest a tag

CryoLife, Inc. At A Glance

Current Price: $9.87
Last Trade Time: 12/4/2008 12:20 PM
Open: $9.29
Previous Close: $9.45
Daily Range: $9.15 - $10.14
52-Week Range: $6.65 - $16.64
Volume: 134,878
Market Cap: $265.88M
P/E Ratio: 20.54
Compare Our Special Broker Offers!

Stock Trends

CRY VS S&P 500 (SPY)

News & Discussion Boards

Other News Headlines for CRY

More Headlines...

Top Bull Pitch

Recs

2

CryoLife, Inc. (CRY)

Avatar cptsintl (81.61) Submitted: 12/02/07 5:27 AM

Despite its dreadful name (derived from cryogenics) CRY has been on a roll from its production standpoint. Bioglue is quickkly spreading its way into ERs and ORs around the country, and around the world. The substance is the best available adhesive for surgery inside the body. Many other products...More

Replies: 0 | Reply | Permalink

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CAPS Members

picks per page. CHANGE

Results 1 - 5 of 30 :   1 2 3 4 5 Next »

Recs

0

 (CRY)

Avatar bigchuck28 (91.57) Submitted: 11/18/08 11:45 PM : Outperform Start Price: $9.66 CRY Score: 1.33

Strong fundamentals.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (CRY)

Avatar xxxpatriate (70.93) Submitted: 10/10/08 9:46 PM : Outperform Start Price: $10.16 CRY Score: 5.45

The recession is just beginning, so look for sectors that do not depend on business growth: health care is an excellent candidate.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (CRY)

Avatar BigChuck (75.26) Submitted: 10/10/08 6:00 PM : Outperform Start Price: $10.16 CRY Score: 5.45

Great potential!

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (CRY)

Avatar dannp (< 20) Submitted: 8/25/08 4:16 PM : Outperform Start Price: $14.29 CRY Score: 0.89

I would love to see this company explode and make it to the top. With the way america's health is according to the news we'll all be needing this company to prosper. I'm hoping they have a good board of directors to lead them into the future.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

 (CRY)

Avatar halcyonsusan (< 20) Submitted: 7/01/08 2:24 PM : Outperform Start Price: $11.28 CRY Score: 19.60

Good new products (high priced and much-required products)

Report this Post Replies: 0 | Reply | Permalink

Results 1 - 5 of 30 :   1 2 3 4 5 Next »

Wall Street

Results 1 - 3 of 3  

picks per page. CHANGE

Top
Pick
Member NameMember RatingStart
Date
CallTime FrameStart
Price
Stock
Gain
S&P
Gain
ScorePitch
TrackRothCapital < 20 03/31/08 Outperform NS $9.73+1.75%-33.81%+35.56
TrackJesupLamont < 20 03/18/08 Outperform NS $8.64+14.58%-33.47%+48.05
TrackPiperJaff < 20 05/02/07 Outperform NS $10.20-2.94%-41.64%+38.70

Results 1 - 3 of 3  

Beat this Stock

Clicking "Beat this Stock!" will bring you to a company with a higher rating than the one you're currently viewing.

Even though CAPS shows only one- to five-star rankings, behind the scenes, all companies in CAPS have a distinct numerical ranking. In other words, there is a No. 1 stock in CAPS and a worst-ranked stock in CAPS. When you arrive at the top-ranked stock, clicking "Beat this Stock!" will cause the page to refresh.

That is, until there is a new No. 1 stock!

These companies do not represent formal Motley Fool recommendations. Please do your own due diligence before investing. Fool on.

Featured Broker Partners

Sponsored Links